Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance

Human Gene Therapy

Volumn 19, Issue 7, 2008, Pages 699-709

  Bennour, Emad ^a,b,c   Ferrand, Christophe ^a,b,c   Rémy Martin, Jean Paul ^a,b,c   Certoux, Jean Marie ^a,b,c   Gorke, Sebastian ^a,d   Qasim, Waseem ^e   Gaspar, H Bobby ^e   Baumert, Thomas ^a,d   Duperrier, Anne ^a,b,c   Deschamps, Marina ^a,b,c   Fehse, Boris ^f   Tiberghien, Pierre ^a,b,c   Robinet, Eric ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GANCICLOVIR; HYBRID PROTEIN; RETROVIRUS VECTOR; THYMIDINE KINASE; TRANSGENIC CD34 ANTIGEN THYMIDINE KINASE FUSION PROTEIN;

ALLOIMMUNITY; ALTERNATIVE RNA SPLICING; ANTIBIOTIC RESISTANCE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG SENSITIVITY; GENE DELETION; GENETIC CODE; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN PROCESSING; RETROVIRUS; SUICIDE GENE; WESTERN BLOTTING; WILD TYPE;

ANTIGENS, CD34; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; LENTIVIRUS; RECOMBINANT FUSION PROTEINS; SIMPLEXVIRUS; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSGENES;

SIMPLEXVIRUS;

EID: 47549104068     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.060     Document Type: Article

References (31)

1. Blumenthal, M., Skelton, D., Pepper, K.A., Jahn, T., Methangkool, E., and Kohn, D.B. (2007). Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Mol. Ther. 15, 183-192.
2. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., and Bordignon, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
3. Burt, R.K., Drobyski, W.R., Seregina, T., Traynor, A., Oyama, Y., Keever-Taylor, C., Stefka, J., Kuzel, T.M., Brush, M., Rodriquez, J., Burns, W., Tennant, L., and Link, C. (2003). Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions. Exp. Hematol. 31, 903-910.
4. Chalmers, D., Ferrand, C., Apperley, J.F., Melo, J.V., Ebeling, S., Newton, I., Duperrier, A., Hagenbeek, A., Garrett, E., Tiberghien, P., and Garin, M. (2001). Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene. Mol. Ther. 4, 146-148.
5. Contag, C.H., and Bachmann, M.H. (2002). Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4, 235-260.
6. Dazzi, F., and Goldman, J.M. (1998). Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu. Rev. Med. 49, 329-340.
7. Deschamps, M., Mercier, P., Certoux, J.M., Henry, C., Lioure, B., Pagneux, C., Cahn, J.Y., Deconinck, E., Tiberghien, P., Robinet, E., and Ferrand, C. (2007). Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T-cells infused with a hematopoietic graft. Blood 110, 3842-3852.
8. Di Ianni, M., Casciari, C., Ciurnelli, R., Fulvi, A., Bagnis, C., Sadelain, M., Lucheroni, F., Mannoni, P., Stella, C.C., Martelli, M.F., and Tabilio, A. (1997). Retroviral transfer of herpes simplex virus-thymidine kinase and β-galactosidase genes into U937 cells with bicistronic vector. Leukemia Res. 21, 951-959.
9. Edinger, M., Cao, Y.A., Verneris, M.R., Bachmann, M.H., Contag, C.H., and Negrin, R.S. (2003). Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101, 640-648.
10. Fehse, B., Kustikova, O.S., Li, Z., Wahlers, A., Bohn, W., Beyer, W.R., Chalmers, D., Tiberghien, P., Kuhlcke, K., Zander, A.R., and Baum, C. (2002). A novel "sort-suicide" fusion gene vector for T cell manipulation. Gene Ther. 9, 1633-1638.
11. +-enriched blood stem cells. Blood 104, 3408-3409.
12. Garin, M.I., Garrett, E., Tiberghien, P., Apperley, J.F., Chalmers, D., Melo, J.V., and Ferrand, C. (2001). Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 97, 122-129.
13. Jonsson, J.J., Habel, D.E., and McIvor, R.S. (1995). Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase gene. Hum. Gene Ther. 6, 611-623.
14. Junker, K., Koehl, U., Zimmerman, S., Stein, S., Schwabe, D., Klingebiel, T., and Grez, M. (2003). Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther. 10, 1189-1197.
15. Kurdow, R., Schniewind, B., Boehle, A.S., Haye, S., Boenicke, L., Dohrmann, P., and Kalthoff, H. (2004). Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC. Anticancer Res. 24, 827-831.
16. Mercier, P., Deschamps, M., Certoux, J.-M., Sauce, D., Ferrand, C., Deconinck, E., Tiberghien, P., and Robinet, E. (2004). Occurrence of immune responses against foreign transgenes after infusion of suicide gene-expressing donor T-cells concurrently to an allogeneic bone marrow transplantation [abstract, ASH Meeting]. Blood 104, 1746.
17. Moolten, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
18. Moolten, F.L., and Wells, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
19. Moolten, F.L., Wells, J.M., Heyman, R.A., and Evans, R.M. (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
20. Pathak, V.K., and Temin, H.M. (1990). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc. Natl. Acad. Sci. U.S.A. 87, 6024-6028.
21. Pathak, V.K., and Temin, H.M. (1992). 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66, 3093-3100.
22. Qasim, W., Mackey, T., Sinclair, J., Chatziandreou, I., Kinnon, C., Thrasher, A.J., and Gaspar, H.B. (2007). Lentiviral vectors for Tcell suicide gene therapy: Preservation of T-cell effector function after cytokine-mediated transduction. Mol. Ther. 15, 355-360.
23. Rettig, M.P., Ritchey, J.K., Meyerrose, T.E., Haug, J.S., and Dipersio, J.F. (2003). Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease. Mol. Ther. 8, 29-41.
24. Robinet, E., Certoux, J.M., Ferrand, C., Maples, P., Hardwick, A., Cahn, J.Y., Reynolds, C.W., Jacob, W., Hervé, P., and Tiberghien, P. (1998). A closed culture system for the ex vivo transduction and expansion of human T lymphocytes. J. Hematother. 7, 205-215.
25. Sauce, D., Bodinier, M., Garin, M., Petracca, B., Tonnelier, N., Duperrier, A., Melo, J.V., Apperley, J.F., Ferrand, C., Hervé, P., Lang, F., Tiberghien, P., and Robinet, E. (2002). Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 99, 1165-1173.
26. Tiberghien, P., Reynolds, C.W., Keller, J., Spence, S., Deschaseaux, M., Certoux, J.M., Contassot, E., Murphy, W.J., Lyons, R., Chiang, Y., Hervé, P., Longo, D.L., and Ruscetti, F.W. (1994). Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84, 1333-1341.
27. Tiberghien, P., Ferrand, C., Lioure, B., Milpied, N., Angonin, R., Deconinck, E., Certoux, J.M., Robinet, E., Saas, P., Petracca, B., Juttner, C., Reynolds, C.W., Longo, D.L., Hervé, P., and Cahn, J.Y. (2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97, 63-72.
28. Valera, A., Perales, J.C., Hatzoglou, M., and Bosch, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449-456.
29. Verzeletti, S., Bonini, C., Marktel, S., Nobili, N., Ciceri, F., Traversari, C., and Bordignon, C. (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus- leukemia: Clinical follow-up and improved new vectors. Hum. Gene Ther. 9, 2243-2251.
30. Yang, L., Hwang, R., Chiang, Y., Gordon, E.M., Anderson, W.F., and Parekh, D. (1998). Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin. Cancer Res. 4, 731-741.
31. Yoon, Y., Pitts, K., and McNiven, M. (2002). Studying cytoskeletal dynamics in living cells using green fluorescent protein. Mol. Biotechnol. 21, 241-250.